Tiratricol FDA approval: targets and potency in BioQ
Tiratricol FDA approval (Emcitate): ChEMBL shows 68 targets, THRB and THRA top by pChEMBL, and 3 registered trials on ClinicalTrials.gov, as of 2026-11-17.
BioQ Blog
Every BioQ post about pChEMBL: real search results, sources and the query to repeat it.
Tiratricol FDA approval (Emcitate): ChEMBL shows 68 targets, THRB and THRA top by pChEMBL, and 3 registered trials on ClinicalTrials.gov, as of 2026-11-17.
NCT07877584 is a phase 3 NSCLC trial of PD-1 blockade with or without chemotherapy; BioQ adds carboplatin ChEMBL potency and ClinicalTrials.gov context.
Phase 1b/2 trial NCT07646821 adds ropeginterferon alfa-2b to azacitidine in TP53-mutated MDS/AML; ChEMBL, ClinicalTrials.gov and DepMap data as of 2026-11-15.
NCT06966843 tests dantrolene in statin-induced myopathy; BioQ pulls its ChEMBL potency and 7 registered dantrolene trials, data as of 2026-11-11.
RET is not a broad CRISPR dependency in DepMap, yet 29 drugs and 1873 disease links exist; one BioQ query reads seven public resources as of 2026-11-06.
PRMT5 is a common-essential gene in DepMap Chronos data, has 3 listed drugs, and 453 Open Targets diseases; one BioQ query joins all the layers.
NCT07885397 tests sonrotoclax in high-risk MDS; ChEMBL potency and 35 ClinicalTrials.gov studies show what is already known about the drug and its target.
NCT07879612 tests semaglutide in Cannabis Use Disorder; BioQ pulls GLP1R potency from ChEMBL and 349 semaglutide trials from ClinicalTrials.gov.
Type imatinib into BioQ and get its ChEMBL measured targets, potency values, trial counts and PubChem identity in 0.34 engine seconds, data as of 2026-11-06.
NCT07811401 tests lemborexant in postoperative sleep disturbance; BioQ adds ChEMBL potency and 22 ClinicalTrials.gov studies, data as of 2026-11-06.
One BioQ query for ALK returns exact ChEMBL measurements, 17 known drugs and 6477 IC50 values from several sources, as of 2026-11-06, in 1.96 engine seconds.
CDK2 is common essential in DepMap Chronos, has 37 known drugs and ties most to neurodegeneration in Open Targets; one BioQ query, data as of 2026-11-06.